Vascular Therapies | Finanzwire

Basculer en Français

11293	Companies
250967	Keywords
179878	Articles
136836	Press releases

Home
Companies
Vascular Therapies

BRIEF

published on 08/05/2024 at 16:05, 2 years 3 months ago

Vascular Therapies Completes Enrollment in Phase III ACCESS 2 Study for Sirogen

Clinical Trial Vascular Access Sirolimus AV Fistula Hemodialysis
PRESS RELEASE

published on 08/05/2024 at 16:00, 2 years 3 months ago

Vascular Therapies Completes Enrollment in the ACCESS 2 Study, a Phase III Multinational Randomized Clinical Trial of the Sirolimus Eluting Collagen Implant (Sirogen) for the Surgical Creation of Arteriovenous Fistula for Hemodialysis Vascular Access
Vascular Therapies completes enrollment in Phase III ACCESS 2 trial to evaluate perivascular sirolimus for AV fistula in kidney disease patients. Topline results expected Q2 2025

Kidney Disease AV Fistula Vascular Therapies Perivascular Sirolimus ACCESS 2 Trial

Accesswire

Published on 11/06/2026 at 22:15, 21 hours 12 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 6 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 6 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 6 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day 9 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/07/2026 at 13:35, 5 hours 52 minutes ago

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 23 hours 12 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 1 day ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 day ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 1 day ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond

Les Echos

Published on 11/06/2026 at 18:00, 1 day 1 hour ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 1 day 1 hour ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 1 day 1 hour ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 1 day 1 hour ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 1 day 8 hours ago

voting rights

View all LES ECHOS COMFI WIRE